VYNE Therapeutics
VYNE Therapeutics Logo
About VYNE Therapeutics
VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics for the treatment of immuno-inflammatory conditions. Its lead product candidate, VYN201, is a locally administered pan-bromodomain and extra-terminal (BET) inhibitor designed to address diseases involving multiple inflammatory cell signaling pathways with low systemic exposure. The company is also developing VYN202, a BD2-selective oral small molecule BET inhibitor for immuno-inflammatory indications. VYNE Therapeutics aims to advance innovative therapies for patients worldwide.
Address
685 Route 202/206 N, Suite 301
Bridgewater, 08807
United States
Year founded
2011
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
